BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nelson CS, Jenks JA, Pardi N, Goodwin M, Roark H, Edwards W, McLellan JS, Pollara J, Weissman D, Permar SR. Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization. J Virol 2020;94:e00186-20. [PMID: 32051265 DOI: 10.1128/JVI.00186-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Spencer Clinton JL, Hoornweg TE, Tan J, Peng R, Schaftenaar W, Rutten VPMG, de Haan CAM, Ling PD. EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice. Vaccine 2022:S0264-410X(22)00891-X. [PMID: 35879117 DOI: 10.1016/j.vaccine.2022.07.016] [Reference Citation Analysis]
2 Bilgilier C, Schneider M, Kührer K, Kilb N, Hartl R, Topakian T, Kastner MT, Herz T, Nelson CS, Permar SR, Roth G, Steininger C. Heterosubtypic, cross-reactive immunity to human Cytomegalovirus glycoprotein B. Clin Exp Immunol 2022;208:245-54. [PMID: 35395673 DOI: 10.1093/cei/uxac031] [Reference Citation Analysis]
3 Karam M, Daoud G. mRNA Vaccines: Past, Present, Future. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.05.003] [Reference Citation Analysis]
4 Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 2022;7:94. [PMID: 35322018 DOI: 10.1038/s41392-022-00950-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
5 Alexander AL, Doyle E, Ingham AB, Colditz I, McRae G, Alkemade S, Cervantes MP, Hine BC. The innate immune stimulant Amplimune® is safe to administer to young feedlot cattle. Aust Vet J 2022. [PMID: 35224736 DOI: 10.1111/avj.13156] [Reference Citation Analysis]
6 Semple SC, Leone R, Barbosa CJ, Tam YK, Lin PJC. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics. Pharmaceutics 2022;14:398. [DOI: 10.3390/pharmaceutics14020398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Machado BAS, Hodel KVS, Fonseca LMDS, Mascarenhas LAB, Andrade LPCDS, Rocha VPC, Soares MBP, Berglund P, Duthie MS, Reed SG, Badaró R. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines (Basel) 2021;9:1345. [PMID: 34835276 DOI: 10.3390/vaccines9111345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jeeva S, Kim KH, Shin CH, Wang BZ, Kang SM. An Update on mRNA-Based Viral Vaccines. Vaccines (Basel) 2021;9:965. [PMID: 34579202 DOI: 10.3390/vaccines9090965] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Liu T, Liang Y, Huang L. Development and Delivery Systems of mRNA Vaccines. Front Bioeng Biotechnol 2021;9:718753. [PMID: 34386486 DOI: 10.3389/fbioe.2021.718753] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
10 Sausen DG, Reed KM, Bhutta MS, Gallo ES, Borenstein R. Evasion of the Host Immune Response by Betaherpesviruses. Int J Mol Sci 2021;22:7503. [PMID: 34299120 DOI: 10.3390/ijms22147503] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Long X, Qiu Y, Zhang Z, Wu M. Insight for Immunotherapy of HCMV Infection. Int J Biol Sci 2021;17:2899-911. [PMID: 34345215 DOI: 10.7150/ijbs.58127] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Esposito S, Chiopris G, Messina G, D'Alvano T, Perrone S, Principi N. Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. Vaccines (Basel) 2021;9:523. [PMID: 34069321 DOI: 10.3390/vaccines9050523] [Reference Citation Analysis]
13 Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, Wang Y, Lewis MG, Pierson TC, Barbosa C, Tam Y, Shen X, Ferrari G, Tomaras GD, Montefiori DC, Weissman D, Haynes BF. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. NPJ Vaccines 2021;6:50. [PMID: 33837212 DOI: 10.1038/s41541-021-00307-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
14 Choi KY, El-Hamdi NS, McGregor A. A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs. J Gen Virol 2021;102. [PMID: 33729125 DOI: 10.1099/jgv.0.001579] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Wollner CJ, Richner JM. mRNA Vaccines against Flaviviruses. Vaccines (Basel) 2021;9:148. [PMID: 33673131 DOI: 10.3390/vaccines9020148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, Wang Y, Lewis MG, Pierson TC, Barbosa C, Tam Y, Shen X, Ferrari G, Tomaras GD, Montefiori DC, Weissman D, Haynes BF. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. bioRxiv 2020:2020. [PMID: 33398289 DOI: 10.1101/2020.12.30.424745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
17 Perotti M, Marcandalli J, Demurtas D, Sallusto F, Perez L. Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity. PLoS Pathog 2020;16:e1009169. [PMID: 33370407 DOI: 10.1371/journal.ppat.1009169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Amir M, Brown JA, Rager SL, Sanidad KZ, Ananthanarayanan A, Zeng MY. Maternal Microbiome and Infections in Pregnancy. Microorganisms 2020;8:E1996. [PMID: 33333813 DOI: 10.3390/microorganisms8121996] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
19 PrabhuDas M, Piper JM, Jean-Philippe P, Lachowicz-Scroggins M. Immune Regulation, Maternal Infection, Vaccination, and Pregnancy Outcome. J Womens Health (Larchmt) 2021;30:199-206. [PMID: 33232632 DOI: 10.1089/jwh.2020.8854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, Biolatti M. Where do we Stand after Decades of Studying Human Cytomegalovirus? Microorganisms 2020;8:E685. [PMID: 32397070 DOI: 10.3390/microorganisms8050685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]